|Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial|
AL Zietman, ML DeSilvio, JD Slater, CJ Rossi, DW Miller, JA Adams, ...
Jama 294 (10), 1233-1239, 2005
|Early detection of prostate cancer: AUA Guideline|
HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ...
The Journal of urology 190 (2), 419-426, 2013
|Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation …|
AL Zietman, K Bae, JD Slater, WU Shipley, JA Efstathiou, JJ Coen, ...
Journal of clinical oncology 28 (7), 1106, 2010
|Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer|
MR Smith, FJ McGovern, AL Zietman, MA Fallon, DL Hayden, ...
New England Journal of Medicine 345 (13), 948-955, 2001
|Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline|
SS Chang, BH Bochner, R Chou, R Dreicer, AM Kamat, SP Lerner, ...
The Journal of urology 198 (3), 552-559, 2017
|Changes in body composition during androgen deprivation therapy for prostate cancer|
MR Smith, JS Finkelstein, FJ McGovern, AL Zietman, MA Fallon, ...
The Journal of Clinical Endocrinology & Metabolism 87 (2), 599-603, 2002
|Prostate specific antigen best practice statement: 2009 update|
KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ...
The Journal of urology 189 (1), S2-S11, 2013
|Radiation with or without antiandrogen therapy in recurrent prostate cancer|
WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ...
New England Journal of Medicine 376 (5), 417-428, 2017
|Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …|
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
|Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation|
MJ Zelefsky, DA Kuban, LB Levy, L Potters, DC Beyer, JC Blasko, ...
International Journal of Radiation Oncology* Biology* Physics 67 (2), 327-333, 2007
|Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis|
WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ...
Jama 281 (17), 1598-1604, 1999
|Outcomes of localized prostate cancer following conservative management|
GL Lu-Yao, PC Albertsen, DF Moore, W Shih, Y Lin, RS DiPaola, MJ Barry, ...
Jama 302 (11), 1202-1209, 2009
|Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas|
HA Gay, HJ Barthold, E O’Meara, WR Bosch, I El Naqa, R Al-Lozi, ...
International Journal of Radiation Oncology* Biology* Physics 83 (3), e353-e362, 2012
|Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer|
FJ Fowler Jr, MMN Collins, PC Albertsen, A Zietman, DB Elliott, MJ Barry
Jama 283 (24), 3217-3222, 2000
|American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy|
BJ Davis, EM Horwitz, WR Lee, JM Crook, RG Stock, GS Merrick, ...
Brachytherapy 11 (1), 6-19, 2012
|Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation …|
WU Shipley, LJ Verhey, JE Munzenrider, HD Suit, MM Urie, PL McManus, ...
International Journal of Radiation Oncology* Biology* Physics 32 (1), 3-12, 1995
|Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience|
JA Efstathiou, DY Spiegel, WU Shipley, NM Heney, DS Kaufman, ...
European urology 61 (4), 705-711, 2012
|Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer|
WU Shipley, DS Kaufman, E Zehr, NM Heney, SC Lane, HK Thakral, ...
Urology 60 (1), 62-67, 2002
|Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology …|
RH Mak, D Hunt, WU Shipley, JA Efstathiou, WJ Tester, MP Hagan, ...
Journal of Clinical Oncology 32 (34), 3801, 2014
|Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer|
JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ...
International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010